Home Other Building Blocks 15015-57-3
15015-57-3,MFCD00020164
Catalog No.:AA001MAR

15015-57-3 | Bis(4-hydroxyphenyl)disulfide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$9.00   $7.00
- +
5g
98%
in stock  
$28.00   $20.00
- +
25g
98%
in stock  
$90.00   $63.00
- +
100g
98%
in stock  
$224.00   $157.00
- +
500g
98%
in stock  
$834.00   $584.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA001MAR
Chemical Name:
Bis(4-hydroxyphenyl)disulfide
CAS Number:
15015-57-3
Molecular Formula:
C12H10O2S2
Molecular Weight:
250.3366
MDL Number:
MFCD00020164
SMILES:
Oc1ccc(cc1)SSc1ccc(cc1)O
NSC Number:
132570
Properties
Properties
 
BP:
437.9°C at 760 mmHg  
Form:
Solid  
MP:
150.0 to 154.0 °C  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
175  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
3  
XLogP3:
3.7  

Downstream Synthesis Route

[1]ZhurnalObshcheiKhimii,1957,vol.27,p.3214    J.Gen.Chem.USSR(Engl.Transl.),1957,vol.27,p.3251

[1]Arzneimittel-Forschung/DrugResearch,1952,vol.2,p.455,460

[1]ChemischeBerichte,1956,vol.89,p.775,790

[1]TetrahedronLetters,2006,vol.47,p.9211-9213

[2]AdvancedSynthesisandCatalysis,2015,vol.357,p.2180-2186

[3]Patent:US2019/352288,2019,A1.Locationinpatent:Paragraph0452-0454

[4]Phosphorus,SulfurandSiliconandtheRelatedElements,2010,vol.185,p.34-39

[5]RSCAdvances,2013,vol.3,p.10680-10686

[6]Patent:CN108586299,2018,A.Locationinpatent:Paragraph0021;0022;0023

[7]GreenChemistry,2017,vol.19,p.2491-2495

[8]Patent:CN106631939,2017,A.Locationinpatent:Paragraph0022;0023;0029;0030

[9]NewJournalofChemistry,2003,vol.27,p.1115-1123

[10]OrganicandBiomolecularChemistry,2006,vol.4,p.4514-4525

[11]Phosphorus,SulfurandSiliconandtheRelatedElements,2009,vol.184,p.2553-2559

[12]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.49-54

[13]OrganicLetters,2018,vol.20,p.6274-6278

[14]GreenChemistry,2019,vol.21,p.1432-1438

[15]Organometallics,2011,vol.30,p.4136-4143

[16]DrugDevelopmentResearch,2019,vol.80,p.171-178

[17]TetrahedronLetters,1997,vol.38,p.5437-5440

[18]HeteroatomChemistry,2012,vol.23,p.231-234

[19]Patent:WO2005/65683,2005,A1.Locationinpatent:Page/Pagecolumn100-101

[20]JournalofMolecularCatalysisB:Enzymatic,2015,vol.116,p.113-123

[21]BulletinoftheChemicalSocietyofJapan,1992,vol.65,p.626-627

[22]LettersinOrganicChemistry,2009,vol.6,p.319-320

[23]RSCAdvances,2019,vol.9,p.24025-24029

[24]Synthesis,2008,p.2023-2032

[25]Advancedsynthesisandcatalysis,2012,vol.354,p.2107-2112,6

[26]JournaloftheAmericanPharmaceuticalAssociation(1912),1947,vol.36,p.257,260

[27]JournalfurpraktischeChemie(Leipzig1954),1890,vol.<2>41,p.189

[28]JournalfurpraktischeChemie(Leipzig1954),1890,vol.<2>41,p.189

[29]ChemischeBerichte,1959,vol.92,p.366,369

[30]Tetrahedron,1969,vol.25,p.4583-4591

[31]JournalofPhysicalChemistry,1994,vol.98,p.4069-4075

[32]Patent:WO2004/24715,2004,A1.Locationinpatent:Page67

[33]Patent:US2004/106653,2004,A1.Locationinpatent:Page/Pagecolumn20

[34]Patent:WO2004/45610,2004,A1.Locationinpatent:Page/Pagecolumn61

[35]JournalofMedicinalChemistry,2009,vol.52,p.4973-4976

[36]Langmuir,2010,vol.26,p.1765-1775

[37]Organometallics,2010,vol.29,p.4459-4463

[38]SyntheticCommunications,2011,vol.41,p.1805-1808

[39]IndianJournalofChemistry,SectionA:Inorganic,Physical,TheoreticalandAnalytical,2013,vol.52,p.1019-1025

[40]AngewandteChemie-InternationalEdition,2015,vol.54,p.9991-9995    Angew.Chem.,2015,vol.127,p.10129-10133,5

[1]JournaloftheAmericanPharmaceuticalAssociation(1912),1947,vol.36,p.257,260

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Synthesis and preliminary in vitro biological evaluation of 4-[(4-hydroxyphenyl)sulfanyl]but-3-en-2-one, a 4-mercaptophenol derivative designed as a novel bifunctional antimelanoma agent.

Journal: Journal of medicinal chemistry 20090813

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:15015-57-3 Molecular Formula|15015-57-3 MDL|15015-57-3 SMILES|15015-57-3 Bis(4-hydroxyphenyl)disulfide